MarketCap
Facebook
X
TelegramCountry |
 Israel |
IPO year |
2018 |
Industry |
Biotechnology |
Stock Exchange |
NASDAQ GLOBAL |
Shares |
- |
Market Cap[1] |
$ 5.04 M |
EBITDA (LTM) |
- |
P/E (LTM) |
- |
P/S (LTM) |
- |
EPS (LTM) |
- |
Other stocks of industry "Biotechnology"
| Issuer | Price | % 24h | Market Cap | Exchange | Country | |
|---|---|---|---|---|---|---|
 |
Nurix Therapeutics
NRIX
|
$ 25.55 | 0.83 % | $ 2.21 B | Nasdaq Global Select Market,SPB |  USA |
 |
Kodiak Sciences
KOD
|
$ 89.5 | 2.13 % | $ 4.76 B | Nasdaq Global Market,SPB | USA |
 |
Intellia Therapeutics
NTLA
|
$ 11.26 | 0.4 % | $ 1.22 B | Nasdaq Global Market,SPB | USA |
 |
Novavax
NVAX
|
$ 9.4 | -3.14 % | $ 1.52 B | Nasdaq Global Select Market | USA |
 |
BioLineRx Ltd.
BLRX
|
$ 2.01 | -1.47 % | $ 4.96 B | Nasdaq Capital Market | Israel |
 |
Bristol-Myers Squibb Company
BMY
|
$ 61.57 | 0.15 % | $ 125 B | NYSE,SPB | USA |
 |
Novartis AG
NVS
|
$ 153.93 | 1.86 % | $ 298 B | NYSE |  Schweiz |
 |
NextCure
NXTC
|
$ 5.22 | 4.72 % | $ 14.8 M | Nasdaq Global Select Market | USA |
 |
Ocugen
OCGN
|
$ 0.71 | -4.64 % | $ 222 M | Nasdaq Capital Market | USA |
 |
Ocular Therapeutix
OCUL
|
$ 6.49 | -0.23 % | $ 1.22 B | Nasdaq Global Select Market | USA |
 |
Oragenics
OGEN
|
$ 0.4 | -3.86 % | $ 863 K | NYSE American | USA |
 |
Checkpoint Therapeutics
CKPT
|
- | - | $ 169 M | Nasdaq Capital Market | USA |
 |
Omeros Corporation
OMER
|
$ 16.27 | -1.81 % | $ 1.03 B | Nasdaq Global Select Market | USA |
 |
Oncolytics Biotech
ONCY
|
$ 0.47 | -5.91 % | $ 45.1 M | Nasdaq Global Select Market |  Canada |
 |
ORIC Pharmaceuticals
ORIC
|
$ 8.99 | -31.74 % | $ 789 M | Nasdaq Global Select Market | USA |
 |
Oramed Pharmaceuticals
ORMP
|
$ 4.08 | -1.21 % | $ 169 M | Nasdaq Global Select Market | Israel |
 |
Outlook Therapeutics
OTLK
|
$ 0.51 | -1.71 % | $ 17.7 M | Nasdaq Global Select Market | USA |
 |
Ovid Therapeutics
OVID
|
$ 2.15 | -0.23 % | $ 280 M | Nasdaq Global Select Market | USA |
 |
Sage Therapeutics
SAGE
|
- | - | $ 527 M | Nasdaq Global Select Market,SPB | USA |
 |
Taro Pharmaceutical Industries Ltd.
TARO
|
- | - | $ 1.62 B | NYSE | Israel |
 |
Nuvation Bio
NUVB
|
$ 4.5 | -1.53 % | $ 1.54 B | NYSE | USA |
 |
Puma Biotechnology
PBYI
|
$ 10.85 | -1.54 % | $ 543 M | Nasdaq Global Select Market | USA |
 |
Processa Pharmaceuticals
PCSA
|
$ 1.76 | -2.76 % | $ 2.3 M | Nasdaq Global Select Market | USA |
 |
Vaxcyte
PCVX
|
$ 59.95 | -0.79 % | $ 8.16 B | Nasdaq Global Select Market | USA |
 |
Forma Therapeutics Holdings
FMTX
|
- | - | $ 958 M | Nasdaq Global Market | USA |
 |
Blueprint Medicines Corporation
BPMC
|
- | - | $ 8.14 B | Nasdaq Global Select Market,SPB | USA |
 |
Pfizer
PFE
|
$ 29.8 | -0.78 % | $ 169 B | NYSE,SPB | USA |
 |
Horizon Therapeutics Public Limited Company
HZNP
|
- | - | $ 26.6 B | Nasdaq Global Select Market |  Irlanda |
 |
Pharming Group N.V.
PHAR
|
$ 11.85 | 5.8 % | $ 8.16 B | Nasdaq Global Select Market |  Niderland |
|
Phathom Pharmaceuticals
PHAT
|
$ 5.94 | 3.48 % | $ 433 M | Nasdaq Global Select Market,SPB | USA |
 |
Phio Pharmaceuticals Corp.
PHIO
|
$ 0.87 | 2.04 % | $ 5.21 M | Nasdaq Capital Market | USA |
 |
Lantern Pharma
LTRN
|
$ 0.6 | -5.34 % | $ 6.54 M | Nasdaq Global Select Market | USA |
 |
Paratek Pharmaceuticals
PRTK
|
- | - | $ 121 M | Nasdaq Global Market | USA |
 |
Pliant Therapeutics
PLRX
|
$ 0.85 | -1.64 % | $ 52.2 M | Nasdaq Global Select Market | USA |
 |
ASLAN Pharmaceuticals Limited
ASLN
|
- | -14.27 % | $ 1.7 M | Nasdaq Global Market |  Singapore |
 |
Adverum Biotechnologies
ADVM
|
- | - | $ 86.2 M | Nasdaq Global Market | USA |
 |
Unity Biotechnology
UBX
|
- | -33.41 % | $ 3.37 M | Nasdaq Global Select Market | USA |
 |
Praxis Precision Medicines
PRAX
|
$ 267.68 | 5.82 % | $ 6.02 B | Nasdaq Global Select Market,SPB | USA |
 |
PainReform Ltd.
PRFX
|
$ 0.74 | 0.07 % | $ 480 K | Nasdaq Capital Market | Israel |
 |
Prelude Therapeutics Incorporated
PRLD
|
$ 3.69 | 1.65 % | $ 284 M | Nasdaq Global Select Market | USA |
 |
iTeos Therapeutics
ITOS
|
- | - | $ 411 M | Nasdaq Global Market | USA |
 |
ProQR Therapeutics N.V.
PRQR
|
$ 1.23 | -4.65 % | $ 130 M | Nasdaq Global Market | Niderland |
 |
Prothena Corporation plc
PRTA
|
$ 8.38 | 2.2 % | $ 451 M | Nasdaq Global Select Market,SPB | USA |
 |
PTC Therapeutics
PTCT
|
$ 61.04 | 0.74 % | $ 4.85 B | Nasdaq Global Select Market,SPB | USA |
 |
Protagonist Therapeutics
PTGX
|
$ 140.24 | 1.31 % | $ 8.92 B | Nasdaq Global Select Market | USA |
 |
Pulmatrix
PULM
|
$ 1.44 | -2.7 % | $ 5.26 B | Nasdaq Global Select Market | USA |
 |
Seelos Therapeutics
SEEL
|
- | -47.76 % | $ 6.27 M | Nasdaq Capital Market | USA |
 |
Advaxis
ADXS
|
- | -9.65 % | $ 45.9 M | Nasdaq Capital Market | USA |
 |
Atossa Therapeutics
ATOS
|
$ 2.45 | -5.91 % | $ 21.1 M | Nasdaq Capital Market | USA |
 |
Ultragenyx Pharmaceutical
RARE
|
$ 16.09 | 2.78 % | $ 1.59 B | Nasdaq Global Select Market,SPB | USA |
References
- Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.